ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease

NCT01607398 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: ADOAIR250
DRUG: Placebo

Sponsor

GlaxoSmithKline